WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: GG 249

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on GG 249

Proof of use for GG 249

We do not have any records of a proof of use for GG 249 at this moment.

Click here to add a proof of use for GG 249

Possible trademark infringements of GG 249

Basic Information about GG 249

Serial Number
90526274
Filing Date
12 Feb 2021
Registration Number
6626856
Registration Date
25 Jan 2022
Mark Drawing Code
4

Classifications

Declare the trademark use of GG 249 on the blockchain with WikiTrademarks.io.

First use of GG 249 anywhere
GG 249 was first used on 01 Sep 1993 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052

Who owns GG 249?

1. SANDOZ AG BASEL

2. Novartis AG Basel

3. Novartis AG Basel

4. Novartis AG Basel

Correspondent

Maury M. Tepper, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH NC 27609

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on GG 249